SCIENTIST HOME FUTURE HEALTH LTD

As of June 30, 2026, SCIENTIST HOME FUTURE HEALTH LTD carries a market capitalization of 45.06M, placing it among publicly traded companies globally. Its enterprise value stands at 45.43M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, SCIENTIST HOME FUTURE HEALTH LTD has 23.72M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 112.44, and the price-to-book ratio stands at -521.99.

These figures are as of June 30, 2026. The EV/Sales ratio of 113.37 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 45.43M versus a market cap of 45.06M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, SCIENTIST HOME FUTURE HEALTH LTD maintains a current ratio of 0.37, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -124.27, reflecting losses generated across the asset base. Inventory turnover of 14.18 indicates how many times SCIENTIST HOME FUTURE HEALTH LTD sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, SCIENTIST HOME FUTURE HEALTH LTD generated 400,738.00 in revenue and converted that into -400,495.00 in net income, yielding earnings per share of -0.02. EBITDA reached -329,686.00, while operating income came in at -400,495.00.

As of June 30, 2026, SCIENTIST HOME FUTURE HEALTH LTD holds 9,047.00 in cash and equivalents against 379,225.00 in total debt, resulting in a net debt position of 18,743.00. Total book value stands at -86,324.00, with working capital of -214,975.00 providing operational flexibility.

SCIENTIST HOME FUTURE HEALTH LTD produced -322,808.00 in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, SCIENTIST HOME FUTURE HEALTH LTD posted a gross margin of 34.15, reflecting its pricing power and cost economics. The operating margin of -99.94 and net profit margin of -99.94 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -0.72: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -0.66, meaning SCIENTIST HOME FUTURE HEALTH LTD raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, SCIENTIST HOME FUTURE HEALTH LTD has an Altman Z-Score of 40.47, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.